The Delhi Pollution Control Committee (DPCC), along with the Government of NCT of Delhi, has submitted a detailed status report to the Hon’ble National Green Tribunal (NGT) in response to the tribunal’s order dated May 6, 2024. The report addresses the compliance of pharmaceutical companies in Delhi with environmental norms, as highlighted in the news article titled "Impact of Pharmaceutical Toxicity on the Environment and Its Regulatory Aspects," published in Current Science on February 25, 2024.
The NGT took up the matter on May 6, 2024, following concerns raised in the news article regarding the environmental impact of pharmaceutical toxicity. The tribunal issued notices to 76 respondents, including the DPCC, requesting reports on compliance with environmental norms by pharmaceutical companies, regulatory guidelines in force, and actions taken against non-compliant companies.
In compliance with the NGT's order, the DPCC submitted its status report, which includes the following key points:
Non-Existence of Bulk Drug Manufacturing Units in Delhi:
Pharmaceutical Formulation and Alternative Medicine Units:
Consent and Compliance:
The report provides specific data regarding the number of operational units and the actions taken against non-compliant entities:
Leave a comment